Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday, 30 September 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 474 (TSX: $VLNS.TO) (OTCQX: $VLNCF) (TSXV: $NDVA.V) (OTCQX: $NDVAF)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 474 (TSX: $VLNS.TO) (OTCQX: $VLNCF) (TSXV: $NDVA.V) (OTCQX: $NDVAF)

 

Today’s podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland

 


Delta, Kelowna, BC, September 30, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/093020-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/09302CSUI-VLNS-VLNCF-NDVA-NDVAF.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

In today’s podcast we look at a few public and private company announcements.

Hyasynth, a sustainable biotechnology company, announced taking the top spot from global competitors by making the first ever sale of cannabidiol (CBD) produced and extracted from yeast. Hyasynth produces CBD through a yeast fermentation process, without the need for traditional cultivation and extraction from cannabis or hemp plants. The material was produced using Hyasynth's proprietary yeast under contract by a fermentation partner. This production marks a key commercialization achievement and positions the company to move towards large scale commercial manufacturing.

 

Hyasynth was among the first companies to specialize in cannabinoid production by fermentation, also called cellular agriculture or biosynthesis - a field that has seen more than $500 million in investments over the last three years. Cannabinoids that are produced this way are expected to provide huge benefits in cost, quality and sustainability versus traditional plant cultivation and extraction. Hyasynth's platform allows it to produce CBD, one of only two natural cannabinoids in clinically proven products. The company's primary competitors have recently announced work on CBG, the precursor to CBD, which is easier to make but lacks an established market.

 

Hyasynth's fermentation process takes less than one week to complete, making it 12 times faster than production by cannabis or hemp plants. Fermentation is a traditional manufacturing process for pharmaceutical, food and cosmetic products. A widely known example of this process is the production of insulin by bacteria. Unlike other production methods, fermentation results in natural, bio-based products and final ingredients that are pesticide and GMO-free. Hyasynth's technology can be scaled through partnerships with fermentation facilities that already exist worldwide. With these product features, Hyasynth is set to reshape the industry for major cannabinoids, like THC and CBD, and rare cannabinoids that are found in very low levels in cannabis and hemp plants.

 

While an increasing number of medical researchers and consumers are finding benefits from CBD, many CBD suppliers and products have recently been warned by regulatory agencies for listing false information on the quantity of CBD and type of ingredients in their products. Hyasynth's technology provides a reliable option for the global supply chain.

 

"Our head start in this area was a key factor in us being the first to reach commercial sale of CBD and CBDa produced from a reliable and sustainable source." said Kevin Chen, CEO of Hyasynth. "We've assembled an excellent team of researchers, built an IP portfolio across many cannabinoids, and our production & sale achievement is one of the last checkpoints before we make our solution available worldwide." The company is in the process of scaling up its CBD and CBDa production process to industrial volumes and aims to deliver scaled production in 2021.

 

The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) announced the launch of a new higher potency cannabis-infused beverage, Summit 10, under a white label agreement with A1 Cannabis Company (a subsidiary of Iconic Brewing).

 

Summit 10, a lemonade iced tea containing 10mg of THC, is the third addition to The Valens Company and A1's line of cannabis-infused beverages. Available in a 355ml bottle, Summit 10 differentiates from the previously released 2.5mg THC-infused Summit beverage, with a flavour profile of citrus and black tea and a higher potency level.  Summit 10 was developed using SōRSE by Valens emulsion technology and is designed for consumers seeking a higher dosage product with faster observed onset times and reduced offset times, housed in a resealable bottle for convenient and controlled consumption.

 

Earlier this year, The Valens Company introduced its first line of cannabis infused beverages in partnership with A1 Cannabis – Basecamp, a CBD-forward iced tea, and Summit, a THC-forward citrus-flavoured water. Both have quickly gained popularity in the Canadian cannabis-infused beverage market, receiving acclaim for their differentiated taste and customizable dosing from the industry and consumers alike.

 

"As an anticipated addition to A1's cannabis-infused beverage line, we bring Summit 10 to the Canadian market, a reimagined THC-forward formulation with more potency and differentiated taste, but with the same quality consumers have come to favour in Summit," said Tyler Robson, Chief Executive Officer of The Valens Company. "As the Canadian cannabis-infused beverage market matures, it is our commitment to continue to innovate and differentiate for our partners using SōRSE by Valens, but also reinvent trusted products that offer customizable experiences in various potency levels and taste profiles to meet a wide range of consumer preferences. We are thrilled to launch Summit 10 as part of our continued collaboration with A1 Cannabis to introduce new products and increase our collective market share in the rapidly growing beverage segment in Canada."

 

Summit 10 is expected to first launch in mid-October in Alberta online and at select retailers, with British Columbia and Ontario to follow shortly after. The Valens Company and A1 Cannabis also expect to release a zero sugar Summit 10 beverage this fall.

 

Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF), the parent company of Indiva Inc., a leading Canadian producer of cannabis edibles and other cannabis products, announced that the first three flavours of Wana™ Sour Gummies have shipped to Alberta, Saskatchewan, and Yukon Territory. Mango Sativa (5 mg THC per gummie), Watermelon Hybrid (5 mg THC per gummie), and Strawberry Lemonade 1:1 (5 mg THC, 5 mg CBD per gummie) are expected to be in stores this week.

 

“We’re thrilled to have shipped Wana™ Sour Gummies to Alberta, Saskatchewan, and Yukon Territory, increasing Wana™’s presence to four provinces and one territory,” said Niel Marotta, President and Chief Executive Officer of Indiva. “In less than a month since Wana™ Sour Gummies were launched, we’ve seen a steady growth in popularity for these vegan and gluten-free cannabis edibles. Of-age Canadians across the country are experiencing first-hand why Wana™ Brands is the No. 1 edibles brand in the United States.”

 

Wana™ Sour Gummies are made with pectin, not gelatin, which gives the gummies a great texture in addition to making them vegan. All gummies are handcrafted using a shelf-stable recipe so they won’t melt. Following the first three flavours that have been released, the Company intends to bring these additional flavours to market later in 2020:

      Blueberry Indica (5 mg THC per gummie)

      Strawberry 10:1 (10 mg CBD, 1 mg THC per gummie)

      Japanese Citrus Yuzu 2:1 (10 mg CBD, 5 mg THC per gummie)

      Pomegranate Blueberry Acai 5:1 (25 mg CBD, 5 mg THC per gummie)

 

Wana™ Brands is the No. 1 edibles brand in the United States, with more dollars sold than any other brand, according to BDSA 2019 Brand Share Report.

 

ANC Inc, Alberta's first licensed micro cultivator, announced the continuation of their national expansion with approval to supply seeds for the commercial and home grower in British Columbia, Alberta, Saskatchewan, Ontario and most recently, New Brunswick.

"Since 2017, ANC Cannabis has been forming a company built around the belief that we can create quality product that is accessible to everyone while also providing educational support and services to our consumers," said Tairance Rutter, ANC Inc.'s VP Business Development and Marketing. Adding, "At ANC we are motivated by a passion for quality product and support for the entire growing and cultivation community. We believe that everyone, no matter their background or experience, should be able to grow their own quality cannabis plants."

 

ANC is first and foremost a genetics company committed to developing the highest quality products possible. ANC is currently focused on seeds for the consumer and commercial market, with plans to release flower for retail sale in the late fall of 2020. The company has been approved for a processing licence so they can process their own product. The company has additional long-term plans to sell flower, likely in the form of pre-rolls sourced from the genetics they will be offering consumers as seed stock. This approach will allow consumers to experience the product before deciding on a cultivar. This will be part of a larger program the company calls the "Know Before You Grow" service, which will also include access to an online platform offering genetics-specific tips for home growers.  ANC Inc's VP of Research and Quality Control, Thomas Facciolo, is excited to provide answers for all our home growers' questions.

 

"ANC continues to expand at a rapid pace, and we are elated to have reached the milestone of national distribution, spanning across Canada, from the West Coast in British Columbia to the East Coast in New Brunswick," said ANC Inc President, Clayton Bordeniuk. Adding, "this is just the beginning for ANC."

 

ANC has developed hundreds of different genetics that are ready for the recreational market including Fruity Hoops, Pink Lemonade, Pineapple Express, Power Kush, Triple Scoop, Bubba Kush 2.5, Chocolate Cake, Double Chocolate, 34 ST Cookies, Bubba Cheese and Sorbet 33. Each strain offers a different genetic make up, with a wide range of THC concentration, and different flowering periods, appropriate for a variety of climates for indoor and outdoor growers alike.

 

 


Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

Disclosure: Cannabis Suisse Corp. (OTC: CSUI ),is a paid featured company on Investorideas.com Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

Investor Ideas #Potcasts Episode 473- #Cannabis News and #Stocks on the Move; Interview with Cannabis Suisse Corp. (OTC: $CSUI) COO and President @SuisseCorp

Investor Ideas #Potcasts Episode 473- #Cannabis News and #Stocks on the Move; Interview with Cannabis Suisse Corp. (OTC: $CSUI) COO and President @SuisseCorp

 

Alain Parrik discusses company’s operations during COVID-19, new product development plans and upcoming launch of a new brand on Amazon

 


Delta, Kelowna, BC, September 30, 2020 - Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

 


In today’s podcast Investor Ideas interviews Alain Parrik, COO and President of Cannabis Suisse Corp. (OTC: CSUI), where we discuss the company’s operations during COVID-19, new product development plans, as well as their recent announcement regarding their online expansion plans including the upcoming launch of a new brand on Amazon.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/092920-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/09301Interview-CSUI.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Сannabis Suisse Corp. is developing its own line of products including hemp oil, hemp protein, hemp gummies and hemp hearts with all the appropriate certificates and licenses for sale on Amazon.

 

This news follows a recent announcement for online distribution of its cannabis and CBD products with uWeed from their retail outlets and online store (www.uweed.ch).

 

The expansion into online sales of hemp gives the company, headquartered in Switzerland, wider access and inroads into the US markets and legal environment for CBD products as it evolves.

 

Mr. Alain Parrik, COO & Director said, "Amazon is an important distribution outlet for us as we ramp up for expansion across multiple online retail platforms. Introducing a new line of hemp products paves the wave for additional products in the future."

 

Cannabis Suisse Corp. will be in compliance with Amazon rules and respects their position that CBD is currently banned on Amazon but hemp products are not.

 

The Company, as a registered manufacturer of both products will continue to use flowers with the highest concentration of CBD. For the new Amazon product line, oil will be squeezed from the seeds allowing Cannabis Suisse to use the whole plant in its production and benefit from it.

 

When asked about the last few months of business through COVID-19 leading up to their recent announcement of adding hemp based products to Amazon, Patrick commented, “The coronavirus pandemic and the quarantine imposed because of it have changed the habits of people around the world. People work, shop and plan differently. At first, the coronavirus seemed disruptive to business, but the demand for cannabis during quarantine is greater than ever before. Sales in the US were up 159% by mid-March, according to Headset. Sales of beverages with added cannabis increased by 14% and sales of edible products increased by 28%. The report also says that because the virus infects the respiratory systems, consumers choose to eat or drink cannabis rather than just smoke it.”

 

Parrick continued, saying, “The recent outbreak of the coronavirus disease did not affect the company’s operations. In fact, due to worrying about the health, and being forced to stay at home people started becoming more curious of the positive effects of CBD. This has lead to increase in demand of the CSUI products in Europe which is surely affecting the operations in a good way. Our Company was able to show its potential in quarantine Covid-19. Under the retail brand, Alpine Cannabis, new product lines have been released.”

 

When asked to discuss in more detail their recent deal with Amazon, Parrick commented, “Amazon is a US company, the largest in the world among online market platforms. Currently it covers 34 product categories and supports individual retail sites for some countries. The platform offers international shipping for some goods as well. The number of platform users is constantly increasing, the company's capitalization is growing accordingly.

 

Cannabis Suisse Corp. believes such a solution is strategically beneficial to increase its revenue and brand awareness. Being a company headquartered in Switzerland, Cannabis Suisse Corp. gains even wider access to the US market, thus the implementation of this intention will have a significant effect on both the growth of the Company and the growth of income of its shareholders. It will also simplify the access of average consumers to the product. Realizing the quality of the product and feeling it on themselves, customers will build a trusting and long-term relationship with the Company, which may affect their desire to become a shareholder of Cannabis Suisse Corp. The Company, as a registered manufacturer of both products will continue to use flowers with the highest concentration of CBD. But for the new Amazon product line, oil will be squeezed from the seeds. In this way, Cannabis Suisse Corp. will be able to use the whole plant in its production and benefit from it.”

 

When asked about the EU CBD and cannabis space right now, (more specifically Switzerland) Alain went on to discuss some of the many benefits as well as the larger issues facing the market so far and how CSUI has stood out in said market.

 

“The Swiss market has a few big competitors now, the rest are small farms with under 1,000 plants in production and mostly outdoor. The big farms have more than 20,000 plants as indoor growing and from 10 to 50 Acers of outdoor growing. During the indoor growing, it is very difficult to get the harvest in good quality so a lot of small farms were closed again in 2018 as it is not possible to make a profit with farms of 1000-3000 plants. We have growers with many years’ experience for indoor grow and our result demonstrates it clearly, we make about 20-gram high-quality flowers heads per plant over an 8-week period. Our progress during this year is not remarkable, but there are some results we have already achieved. In January 2019 we got Grow Factory with facility for 1,700 plants, our possessions have expanded to two more rooms with 2,000 plants and we were running 3,700 plants in total. We have been expanding further since summer 2019 and have more than 5,000 plants now.

 

The biggest issue in Switzerland is to find a landlord for indoor grow who accepts CBD production. But our situation is unique, and we managed to rent the territory of 556.5 m2 and get approval for our 4000 m2 place which is planned to be available on December 1, 2020.

 

The prices on weed have been dumbing in Switzerland, so in order to get a part of the market we have to reduce the price and produce more weed. For the EU market we will make an additional product line with dietary supplements, cosmetic, soft drinks etc.

In 2021 we will organize our working process involving first outdoor field to make 16,000 kg of raw material for our oil production.”

 

When asked what investors should be looking for from CSUI as well as how the Swiss and EU cannabis space might change over the next year, Parrick commented, “There are coming big changes in the EU regulative connected with cannabis nowadays, but in some countries the healthcare department treats CBD only as a medical product and will not allow it as Diet Supplements or Food Supplies. So people can only buy CBD on the internet under their own responsibility. However, we managed to launch the import of CBD-vape oil and Sativa hemp flowers to EU as B2B and direct shops sales. Cannabis Suisse Corp. has forward-looking plans to expand outside Switzerland developing customized products. Some European countries like Germany, Denmark, Malta, Greece, and Italy discussed the possibility of creating a completely regulated cannabis market by 2028. Furthermore, Luxembourg intends to introduce a regulated market for adult use of cannabis by 2023.

 

Based on all of the above advantages of the Company’s products, the situation in the European market and forthcoming amendments to the legislation, the Company’s decision to launch new product lines and enter the EU market is more than an appropriate and timely one.”

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI), is a paid featured company on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 



Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com

 

Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections

Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections : Public Support for Legalization...